Researchers identify genetic marker of relapse for childhood leukemia

05/14/2010 | HealthDay News

Children with T-cell acute lymphoblastic leukemia who carry a unique expression of five genes are likely to relapse, researchers said. The discovery could be used to create screening tests to identify patients who need more aggressive therapy to achieve complete remission, a study co-author said.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC